0001209191-19-010820.txt : 20190215
0001209191-19-010820.hdr.sgml : 20190215
20190215210033
ACCESSION NUMBER: 0001209191-19-010820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190213
FILED AS OF DATE: 20190215
DATE AS OF CHANGE: 20190215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dispersyn Gerrit
CENTRAL INDEX KEY: 0001704417
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 19613095
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-13
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001704417
Dispersyn Gerrit
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
0
1
0
0
President & COO
Common stock
2019-02-13
4
A
0
55000
0.00
A
71350
D
Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
Caitlin Kontulis, attorney-in-fact
2019-02-15